These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26942037)

  • 1. Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease.
    Polito L; Greco A; Seripa D
    Parkinsons Dis; 2016; 2016():6465793. PubMed ID: 26942037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental toxins and Parkinson's disease.
    Goldman SM
    Annu Rev Pharmacol Toxicol; 2014; 54():141-64. PubMed ID: 24050700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
    Dardiotis E; Xiromerisiou G; Hadjichristodoulou C; Tsatsakis AM; Wilks MF; Hadjigeorgiou GM
    Toxicology; 2013 May; 307():17-23. PubMed ID: 23295711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
    Angelopoulou E; Bozi M; Simitsi AM; Koros C; Antonelou R; Papagiannakis N; Maniati M; Poula D; Stamelou M; Vassilatis DK; Michalopoulos I; Geronikolou S; Scarmeas N; Stefanis L
    Parkinsonism Relat Disord; 2019 Oct; 67():105-112. PubMed ID: 31494049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and etiology of Parkinson's disease: a review of the evidence.
    Wirdefeldt K; Adami HO; Cole P; Trichopoulos D; Mandel J
    Eur J Epidemiol; 2011 Jun; 26 Suppl 1():S1-58. PubMed ID: 21626386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental-genetic interactions in the pathogenesis of Parkinson's disease.
    Tsuboi Y
    Exp Neurobiol; 2012 Sep; 21(3):123-8. PubMed ID: 23055790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Gene-Environment Interactions in Parkinson's Disease.
    Fleming SM
    Curr Environ Health Rep; 2017 Jun; 4(2):192-199. PubMed ID: 28417442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.
    Burbulla LF; Krüger R
    J Neurol Sci; 2011 Jul; 306(1-2):1-8. PubMed ID: 21513949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenetic causes of Parkinson's disease.
    Chade AR; Kasten M; Tanner CM
    J Neural Transm Suppl; 2006; (70):147-51. PubMed ID: 17017522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.
    Chin-Chan M; Navarro-Yepes J; Quintanilla-Vega B
    Front Cell Neurosci; 2015; 9():124. PubMed ID: 25914621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice.
    Wu Q; Yang X; Zhang Y; Zhang L; Feng L
    Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple antioxidants in the prevention and treatment of Parkinson's disease.
    Prasad KN; Cole WC; Kumar B
    J Am Coll Nutr; 1999 Oct; 18(5):413-23. PubMed ID: 10511322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease.
    Powers R; Lei S; Anandhan A; Marshall DD; Worley B; Cerny RL; Dodds ED; Huang Y; Panayiotidis MI; Pappa A; Franco R
    Metabolites; 2017 May; 7(2):. PubMed ID: 28538683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.
    Helley MP; Pinnell J; Sportelli C; Tieu K
    Front Genet; 2017; 8():177. PubMed ID: 29204154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.